Insmed

Manufacturing · New Jersey, United States · 1K - 5K Employees

View Company Info for Free

Overview

Headquarters

700 US Highway 202/206, Bridgewater, New...

Phone Number

(908) 977-9900

Revenue

$1.1 Billion

Stock Symbol

INSM

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Insmed

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.Explore more
Insmed's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: INSMShow more

Insmed Org Chart

William Lewis, Chair and Chief Executive Officer at Insmed
United States flag for contact location.

Chair and Chief Executive Officer

PhoneEmail
DN
United States flag for contact location.

Vice President, Technical Operations

PhoneEmail
IF
United States flag for contact location.

Senior VP & Head of Medical Affairs

PhoneEmail
MF
United States flag for contact location.

Senior Vice President Commercial Head of Gene...

PhoneEmail
AG
United States flag for contact location.

Business Development Vice President, Commerci...

PhoneEmail
BA
United States flag for contact location.

Vice President, Development Operations

PhoneEmail
AL
United States flag for contact location.

Vice President, Clinical Development Gene The...

PhoneEmail
LB
United States flag for contact location.

Gene Therapy Vice President, Regulatory Affai...

PhoneEmail
PB
United States flag for contact location.

Vice President, Regulatory Affairs

PhoneEmail
AT
United States flag for contact location.

Vice President, Market Access (US)

PhoneEmail
KC
United States flag for contact location.

Vice President, Field Medical (US)

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
SY
United States flag for contact location.

Executive Director & Head of Clinical Develop...

PhoneEmail
SK
United States flag for contact location.

Drug Safety Head (Japan)

PhoneEmail
TM
United States flag for contact location.

Director & Global Head of the Center of Excel...

PhoneEmail
NM
United States flag for contact location.

Director, Head of Supplhy Chain

PhoneEmail
VM
United States flag for contact location.

Executive Director

PhoneEmail
AP
United States flag for contact location.

QA Executive Director, Development

PhoneEmail
MS
United States flag for contact location.

Executive Director, Clinical Development

PhoneEmail
JD
United States flag for contact location.

Executive Director, Portfolio Strategy & Proj...

PhoneEmail
CB
United States flag for contact location.

Executive Director, Supply Chain & Logistics

Flame icon indicating likelihood to engage via phone.PhoneEmail
CR
United States flag for contact location.

Executive Director, Dspv Medical Safety

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Insmed

Compare insights from companies similar to Insmed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Insmed

$1.1B
1K - 5K
Public
$775M
1988
William Lewis, Chair and Chief Executive Officer at Insmed
William LewisChair and CEO
$3.4B
1K - 5K
Public
$1.5B
1992
$3.2B
1K - 5K
Public
$54M
1996
JR
Jeff RossPresident, Miromatrix
$1.1B
501-1,000
Public
$443M
1993
Mark Schneyer, Chief Financial Officer at Acadia
Mark SchneyerChief Financial Officer
$717M
1K - 5K
Public
$1.6B
2010
Howard Horn, Chief Financial Officer & Executive VP, Corporate Strategy at Ultragenyx
Howard HornChief Financial Officer & Executive VP, Corporate Strategy
$512.3M
501-1,000
Public
$462.6M
2004
Terence Kohler, Chief Financial Officer & Treasurer at ADMA Biologics
Terence KohlerChief Financial Officer & Treasurer
$355.2M
501-1,000
Public
$226.4M
2008
Illustration of an envelope

Insmed Tech Stack

A closer look at the technologies used by Insmed

Top Manufacturing Companies

Frequently Asked Questions Regarding Insmed

What is Insmed's stock symbol?
Insmed's stock symbol is INSM
What is Insmed's official website?
Insmed's official website is www.insmed.com
What is Insmed's Revenue?
Insmed's revenue is $1.1 Billion
What is Insmed's SIC code?
Insmed's SIC: 28,283
What is Insmed's NAICS code?
Insmed's NAICS: 32,325
How many employees does Insmed have?
Insmed has 1K - 5K employees
What industry does Insmed belong to?
Insmed is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Insmed competition?
Insmed top competitors include: ADMA Biologics, Ultragenyx, Neurocrine Biosciences, United Therapeutics
What companies has Insmed acquired?
Insmed has acquired the companies: Transave
What technology does Insmed use?
Some of the popular technologies that Insmed uses are: DocuSign, WordPress.org, PHP, Microsoft SharePoint
What does Insmed do?

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients... . It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.Read More

What are Insmed social media links?
Insmed Linkedin page Insmed Twitter page
Is Insmed a public company?
Yes, Insmed is a public company and is traded under the symbol INSM
See more information about Insmed

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.